COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.
Stay current on PCCA news and events, market trends, and all things compounding!
Rectal conditions can be difficult and painful to deal with, especially Crohn's disease, ulcerative proctitis and radiation proctitis. Nat Jones explains how compounding pharmacists have a unique knowledge to help those afflicted. He also provides specific formulation information geared toward providing relief.
Medicated lozenges are common in the pharmacy world. There's nothing common about NataTroche™ though, it's the first proprietary troche made with natural ingredients and free of polyethylene glycol or gelatin. Find out what makes NataTroche so special, and how it can help you and your patients.
Daniel Banov talks about water activity in various products and why they are becoming increasingly important in the pharmacy compounding world.
Tadalafil is now free of patents, and compounding pharmacies have some opportunities to use this drug in various customized medications. PCCA's Nat Jones drops in to tell us why that is such exciting news for compounding pharmacies and their patients.
Attending C3 with fellow compounding professionals means a stronger community for compounding pharmacies. It means meeting folks like Max, Lisa, and Denise, three pharmacists who recently completed C3. We asked them a few questions about their C3 experience and this is what they had to say.
Devaki Lindsey Berkson, a well-respected nutritionist and hormone research expert, and what she has to say might just change the way you think about the "cuddle chemical"--Oxytocin.
Mike and Seb had a tremendous January, meeting with industry leaders Dr. Pamela Wartian Smith, Saad Dinno, and Bryan Prescott. You can connect to the best pharmacy compounding podcast on the web right here!
January updates for PCCA Play! Doctor Pamela W. Smith explains the importance of hormones and GI health and how they affect the skin. Also, a sneak peek at Doctor Valcinir Bedin's Chemical Peels and Resurfacing lecture that goes live on January 24th.
We’re excited that patients and physicians now have access to Azelastine Hydrochloride USP as an ingredient option in compounded medications. There are some commercial products available, including a combination product, but when those items don’t fit the specific needs of patients, we need to put on our thinking caps and start looking for other options for them. We’re sure that you compounders out there can come up with a few of your own as well.
By Maria Carvalho, PharmD, MRPharmS, PhD. She is the Manager of PCCA Science.